Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MALIGNANT PLEURAL MESOTHELIOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00253409
What this trial is testing

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
Institute of Cancer Research, United Kingdom 670
Early research (Phase 1)WithdrawnNCT02639767
What this trial is testing

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Testing effectiveness (Phase 2)Study completedNCT05278975
What this trial is testing

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Who this might be right for
Malignant Pleural EffusionMalignant Pleural MesotheliomaMesothelioma+3 more
RS Oncology LLC 50
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06535607
What this trial is testing

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca
Not applicableLooking for participantsNCT06946498
What this trial is testing

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

Who this might be right for
Suspected Malignant Lung NeoplasmPleural EffusionPleural Effusion, Malignant+1 more
National and Kapodistrian University of Athens 100
Not applicableStudy completedNCT04843007
What this trial is testing

Alvopem® (Pemetrexed) Safety Assessment

Who this might be right for
Non Small Cell Lung CancerMalignant Pleural Mesothelioma
NanoAlvand 199
Not applicableUnknownNCT02040272
What this trial is testing

Mesothelioma and Radical Surgery 2

Who this might be right for
Mesothelioma
Royal Brompton & Harefield NHS Foundation Trust 328
Not applicableUnknownNCT03290183
What this trial is testing

Confocal Laser Endomicroscopy in Pleural Malignancies

Who this might be right for
Pleural Malignant MesotheliomaThymomaPleural Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)UnknownNCT05429866
What this trial is testing

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Who this might be right for
Breast CancerMelanomaNon Small Cell Lung Cancer+10 more
Jules Bordet Institute 441
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)Study completedNCT05380713
What this trial is testing

......SMARTEST Trial......

Who this might be right for
Mesothelioma, Malignant
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT00720954
What this trial is testing

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy

Who this might be right for
Pleural EffusionPleural Diseases
Eskisehir Osmangazi University 124
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Next Page
257